Author:
Jacquemyn Xander,Long Rita,Rao Sruti,Danford David,Barnes Benjamin T.,Kutty Shelby
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Axelsson Raja A, Farhad H, Valente AM, Couce J-P, Jefferies JL, Bundgaard H, Zahka K, Lever H, Murphy AM, Ashley E, Day SM, Sherrid MV, Shi L, Bluemke DA, Canter CE, Colan SD, Ho CY, Towbin J, Russell M, Patel A, Kim B, Taylor M, Mestroni L (2018) Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy. Circulation 138:782–792
2. Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, Haugaa KH, Opdahl A, Fjeld JG, Gjesdal O, Edvardsen T, Smiseth OA (2012) A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work. Eur Heart J 33:724–733
3. Galli E, Vitel E, Schnell F, Le Rolle V, Hubert A, Lederlin M, Donal E (2019) Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis. Echocardiography 36:74–82
4. Hiemstra YL, van der Bijl P, El Mahdiui M, Bax JJ, Delgado V, Marsan NA (2020) Myocardial work in nonobstructive hypertrophic cardiomyopathy: implications for outcome. J Am Soc Echocardiogr 33:1201–1208
5. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P (2020) AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 142(25):e558–e631